22-23181264-G-C

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_004327.4(BCR):​c.304G>C​(p.Ala102Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000725 in 1,103,370 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A102T) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000073 ( 0 hom. )

Consequence

BCR
NM_004327.4 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.27

Publications

0 publications found
Variant links:
Genes affected
BCR (HGNC:1014): (BCR activator of RhoGEF and GTPase) A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The unregulated tyrosine kinase activity of BCR-ABL1 contributes to the immortality of leukaemic cells. The BCR protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac and other kinases. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1384174).
BS2
High AC in GnomAdExome4 at 8 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004327.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCR
NM_004327.4
MANE Select
c.304G>Cp.Ala102Pro
missense
Exon 1 of 23NP_004318.3
BCR
NM_021574.3
c.304G>Cp.Ala102Pro
missense
Exon 1 of 22NP_067585.2P11274-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCR
ENST00000305877.13
TSL:1 MANE Select
c.304G>Cp.Ala102Pro
missense
Exon 1 of 23ENSP00000303507.8P11274-1
BCR
ENST00000359540.7
TSL:1
c.304G>Cp.Ala102Pro
missense
Exon 1 of 22ENSP00000352535.3P11274-2
BCR
ENST00000928588.1
c.304G>Cp.Ala102Pro
missense
Exon 1 of 23ENSP00000598647.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000725
AC:
8
AN:
1103370
Hom.:
0
Cov.:
30
AF XY:
0.00000946
AC XY:
5
AN XY:
528628
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22154
American (AMR)
AF:
0.00
AC:
0
AN:
10200
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13966
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
26112
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34634
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3548
European-Non Finnish (NFE)
AF:
0.00000864
AC:
8
AN:
925622
Other (OTH)
AF:
0.00
AC:
0
AN:
42968
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.64
T
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
2.3
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.72
N
REVEL
Benign
0.067
Sift
Benign
0.15
T
Sift4G
Benign
0.25
T
Polyphen
0.79
P
Vest4
0.13
MutPred
0.13
Gain of catalytic residue at P101 (P = 0.0155)
MVP
0.56
MPC
0.57
ClinPred
0.32
T
GERP RS
2.9
Varity_R
0.14
gMVP
0.26
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs890602494; hg19: chr22-23523451; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.